|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4050 - 0.4407|
|52 Week Range||0.1990 - 1.1390|
|Beta (5Y Monthly)||1.75|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Offering was led by Eight Capital on behalf of a syndicate of underwriters including Canaccord Genuity Corp., BMO Capital Markets, Leede Jones Gable Inc., Raymond James Ltd., Mackie Research Capital Corp., and PI Financial Corp. (together, the “Underwriters”). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.80, for a period of 36 months following the closing of the Offering.
Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) announced that effective today, in connection with the previously announced bought deal financing, the Company’s common shares will trade on the Toronto Stock Exchange under the ticker symbol “AH”. Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that the board of directors (the “Board”) has elected an Acting Chair and reconstituted its committees following the recent addition of Rhonda Lawson and Glenn Washer to the Board. The Board has elected Lea Ray to serve as Acting Chair. Following the Company’s upcoming meeting of shareholders on June 30, 2020, the Board expects to formally elect a new Chair of the Board.
If you're interested in Aleafia Health Inc. (TSE:ALEF), then you might want to consider its beta (a measure of share...
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) announced today that its upcoming annual and special meeting of shareholders (the “Meeting”) will be held on Tuesday, June 30, 2020 at 10:00 a.m. EDT. Given COVID-19, the Company will be holding the Meeting as a completely virtual meeting, which will be conducted via a web interface. Details as to how shareholders may attend the Meeting electronically and vote electronically will be included in the Company’s Meeting materials, which will be posted on SEDAR and mailed in due course.
$13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486% increase over prior year’s quarterPositive cash flow from operations85% gross margin on cannabis net.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) wholly owned subsidiary Aleafia Farms Inc. has secured a Health Canada Licence Amendment for its Port Perry Facility’s outdoor cultivation expansion. The expansion adds an additional 60 acres of licenced outdoor cultivation area, bringing the total to 86 acres (3.7 million sq. ft.). During the inaugural 2019 outdoor cultivation season, the Company harvested 12,747 kgs of dried cannabis flower utilizing 13 acres (of the 26 total acres licensed in 2019) at $0.10 an all-in cash cost per gram to harvest.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia” or the “Company”), is pleased to announce that it has entered into an agreement with Eight Capital as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase 20,000,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Unit of $0.65 (the “Issue Price”) for gross proceeds of $13,000,000 (the “Offering”). Each Unit will be comprised of one common share in the capital of the Company (a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”).
Successful application would allow for cannabis production and export to EU marketEmblem Germany cannabis distribution center to be completed later this monthExperienced senior.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) wholly owned subsidiary Emblem Cannabis Corp. (“Emblem”) has secured a Health Canada Licence Amendment for its Paris Facility’s 30,000 sq. ft. Phase II expansion, entirely dedicated to the extraction, production, packaging and distribution of finished cannabis products. “The Phase II expansion, our crown jewel, permits an exponential increase in our ability to produce and sell high-margin cannabis health and wellness products in the medical, adult-use and international markets,” said Aleafia Health CEO Geoffrey Benic.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that two new independent directors, Rhonda Lawson and Glenn Washer, will be appointed to the Board on May 16. The Company would also like to thank the outgoing directors, Julian Fantino (Chairman) and Raf Souccar, for their devoted service since the company’s inception.
TORONTO — Aleafia Health Inc. says former Ontario Provincial Police commissioner and federal cabinet minister Julian Fantino is resigning from the company's board.The Toronto-based medical cannabis company says former RCMP deputy commissioner Raf Souccar is also departing.A release from the company did not offer any explanation for the resignations, but says they are effective May 15.Fantino served as Aleafia's chairman and Souccar was a director.Fantino's involvement in the company was met with criticism because he was a longtime cannabis opponent and once compared legalizing the substance to legalizing murder in an interview with the Toronto Sun.Aleafia says Fantino and Souccar oversaw the acquisition of licensed cannabis producer Emblem Corp. and the company's Port Perry, Ont. facility.This report by The Canadian Press was first published April 28, 2020.Companies in this story: (TSX:ALEF) The Canadian Press
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that the Hon. Julian Fantino and Raf Souccar have today indicated their intention to resign as directors of the Company effective May 15, 2020. On behalf of the Aleafia Health team, the Company wishes to thank Messrs.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) AssureHome Delivery™, Canada’s only fast, direct-to-door delivery service, has launched industry-leading next day distribution of medical cannabis products. “With COVID-19 negatively affecting third-party delivery service times, we are demonstrating that our commitment to patients does not end until medicine is safely in their hands.”
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to provide a comprehensive corporate update on strategic growth initiatives. “Aleafia Health’s focus on disciplined, sustainable and scalable growth is more important now than ever with the launch of two major initiatives to adapt to patients’ needs during COVID-19,” said Aleafia Health CEO Geoffrey Benic.
TORONTO, April 14, 2020 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2020 first quarter results on May 13, 2020 prior to.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) is launching its last-mile medical cannabis home delivery service. It will provide patients next-day, direct-to-home delivery on medical cannabis orders made in Ontario’s Greater Golden Horseshoe Region (“GGHR”), home to over 9 million people. It also mitigates the risk to the Company of disruption of postal and third-party parcel delivery services during the COVID-19 pandemic.
First quarterly positive adjusted EBITDA of $0.2M in Q4 201927% increase in Q4 2019 net cannabis revenue over the previous quarter1,748% increase in FY 2019 net cannabis revenue.
NEW YORK, NY / ACCESSWIRE / March 18, 2020 / Aleafia Health, Inc. (OTCMKTS:ALEAF) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 18, 2020 at 8:30 ...
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Aleafia Farms Inc., has secured a Health Canada Cultivation Licence (the “Licence”) for the Company’s Niagara Production Facility (the “Niagara Facility”), located in Grimsby, Ont. “The Niagara Facility provides both near term, stable inventory for our health and wellness sales channels, and the inputs needed for the 2020 outdoor cultivation season.”
TORONTO, Feb. 25, 2020 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 fourth quarter and fiscal year results on March.
TORONTO, Jan. 24, 2020 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), a global cannabis health and wellness company, is pleased.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary, Emblem Cannabis Corporation, has reached a definitive licensing agreement (the “Agreement”) with Kinstate, Inc. (“Kinstate”) to bring its award-winning, cannabis-infused sublingual strips brand and underlying sublingual strip technology to the Canadian medical and adult-use cannabis market. The Agreement provides the Company with the exclusive Canadian rights to manufacture, market and sell certain Kin Slips products, along with rights to use the associated proprietary formulations, manufacturing methodology and intellectual property provided by Kinstate and options for the Company to offer the format into certain other international markets.